Project Details
| Acronym | LYT-100-2020-01 |
|---|---|
| Status | Active |
| Effective start/end date | 1/08/20 → 25/06/25 |
A Phase 1/1b Multiple Ascending Dose and Food Effect Study in Healthy Volunteers to Determine the Pharmacokinetics and Maximally Tolerated Dose of Deupirfenidone (LYT-100) Followed by Further Exploration in Patients with Breast Cancer-Related Upper Limb Secondary Lymphoedema
- Mackie, Helen (Primary Chief Investigator)
- Koelmeyer, Louise A (Associate Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Rai, Meenal (Clinical Trial Unit Staff)
Project: Research